Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HCV / HEPATITIS VIDEOS - Page 1

Does Cabotegravir Interact with Any Other Medications?
Alex Rinehart, PhD, explains if cabotegravir interacts with any other medications.
Reducing the Incidence of Acute Kidney Injury from Vancomycin & Pip/Tazo
Megan Luther, PharmD, Advanced Health Services research fellow, Providence Veterans Affairs Medical Center, University of Rhode Island, College of Pharmacy, discusses potential strategies to reduce incidence of acute kidney injuries due to vancomycin and pip/tazo combination therapy.
Improving Hepatitis C Incidence in the US
Monique Foster, MD, MPH, EIS officer, Division of Viral Hepatitis, Centers for Disease Control and Prevention (CDC), discusses the CDC’s HCV universal birth cohort testing program.
Investigating HCV Infection Awareness Prior to NHANES Tests
Monique Foster, MD, MPH, EIS officer, Division of Viral Hepatitis, Centers for Disease Control and Prevention, explains that hepatitis C infection awareness has been on the rise in the United States.
Importance of New Hepatitis C Treatments
Monique Foster, MD, MPH, EIS officer, Division of Viral Hepatitis, Centers for Disease Control and Prevention, discusses the importance of new medications to treat hepatitis C.
Examining the Prevalence of HCV Infection Awareness in the US
Monique Foster, MD, MPH, EIS officer, Division of Viral Hepatitis, Centers for Disease Control and Prevention, explains why it’s important for individuals to know that they are infected with hepatitis C, although they may be asymptomatic.
Direct-Acting Antiviral's Impact on Patients' Adherence to HCV Drug Regimen
Charitha Gowda, MD, MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the impact direct-acting antivirals have had on patients’ adherence to their drug regimen when treating hepatitis C.
How Does the Treatment Regimen Differ for Acute HCV vs. Chronic HCV?
Charitha Gowda, MD, MPH, Infectious diseases physician at Penn Presbyterian Medical Center explains how  the treatment regimen for treating those with acute hepatitis C differs from chronic hepatitis C.
FEATURED
Big advances in treatment can